Steris (STE) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $218.44 -2.74%
EPS Growth %: +8.5%
Financial Fact:
Research and development: 14.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +8.5%
Financial Fact:
Research and development: 14.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.
GUIDANCE:
Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $7.91.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- B.Riley Starts Better Home & Finance Holding (BETR) at Buy
- JPMorgan Downgrades AVI Limited (AVI:SJ) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
